Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and EHS Tumor

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clegg, ST; Craciunescu, OI; Das, SK1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and EHS Tumor

ArticleYear
Dynamic contrast-enhanced MRI and fractal characteristics of percolation clusters in two-dimensional tumor blood perfusion.
    Journal of biomechanical engineering, 1999, Volume: 121, Issue:5

    Topics: Animals; Contrast Media; Dogs; Forelimb; Fractals; Heterocyclic Compounds; Hindlimb; Image Enhancement; Least-Squares Analysis; Magnetic Resonance Imaging; Organometallic Compounds; Sarcoma, Experimental

1999